Comparison of vessel dilator and long-acting natriuretic peptide in the treatment of congestive heart failure.

@article{Vesely1999ComparisonOV,
  title={Comparison of vessel dilator and long-acting natriuretic peptide in the treatment of congestive heart failure.},
  author={David L. Vesely and John R Dietz and John S Parks and E A Antwi and Rose M Overton and Michael T. McCormick and Guillermo Cintron and Douglas D. Schocken},
  journal={American heart journal},
  year={1999},
  volume={138 4 Pt 1},
  pages={625-32}
}
BACKGROUND Long-acting natriuretic peptide (LANP; proANF 1-30) and vessel dilator (proANF 31-67) enhance sodium and water excretion in healthy human beings. The current investigation was designed to compare the beneficial effects of LANP and vessel dilator in persons with congestive heart failure (CHF). METHODS AND RESULTS LANP and vessel dilator (100 ng/kg body weight/min, respectively) were given intravenously for 60 minutes to subjects with New York Heart Association class III CHF (n = 17… CONTINUE READING